Nanotechnology Now

Our NanoNews Digest Sponsors



Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > New Pediatric Nanomedicine Center Links Health Care and Engineering

Abstract:
Physicians and engineers within a new center devoted to pediatric nanomedicine will develop targeted, molecular-sized nanoparticles as part of a unique approach to treating pediatric diseases. Specific focus areas will include pediatric heart disease and thrombosis, infectious diseases, cancer, sickle cell disease and cystic fibrosis.

New Pediatric Nanomedicine Center Links Health Care and Engineering

Atlanta, GA | Posted on March 30th, 2011

The Center for Pediatric Nanomedicine (CPN) is the first of its kind in the world.

Directed by Gang Bao, the center will involve researchers from Emory University, the Georgia Institute of Technology and Children's Healthcare of Atlanta.

"Because nano-scale structures are compatible in size to biomolecules, nanomedicine provides unprecedented opportunities for achieving better control of biological processes and drastic improvements in disease detection, therapy and prevention," says Bao, the Robert A. Milton Professor of Biomedical Engineering in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University.

Nanomedicine involves the development of engineered nanoscale structures and devices for better diagnostics and highly specific medical interventions to treat diseases and repair damaged tissues. One nanometer is one-billionth of a meter.

The CPN is part of the Emory-Children's Pediatric Research Center led by the two institutions, including partnerships with Georgia Institute of Technology and Morehouse School of Medicine.

With the leadership of Dr. Paul Spearman, Children's chief research officer and vice chair for research in the Emory University Department of Pediatrics, 14 key priority centers have been identified. These are hematology and oncology; immunology and vaccines; transplant immunology and immune therapeutics; pediatric healthcare technology innovation; cystic fibrosis; developmental lung biology; endothelial biology; cardiovascular biology; drug discovery; autism; neurosciences; nanomedicine; outcomes research and public health; and clinical and translational research.

Emory and Georgia Tech already have had significant and successful research partnerships in nanomedicine funded by the National Institutes of Health. These have included nanotechnology center of excellence for the detection and treatment of cardiovascular disease, the development of personalized and predictive oncology, and the development of engineered protein machines for treating single-gene disorders.

"Nanotechnology can be applied to many diseases, and the application of nanotechnology could have a profound impact on improving children's health," says Bao.

Current centers located in the joint Georgia Tech-Emory biomedical engineering department include the Center for Translational Cardiovascular Nanomedicine (funded by a $14.6 million, five-year grant from NHLBI/NIH) and the Nanomedicine Center for Nucleoprotein Machines (funded by a $16.1 million, five-year grant from NIH).

The discoveries made in these centers also will be applied to research in pediatric diseases. For example, scientists in the center for nucleoprotein machines are focused on developing a technology to correct single-gene defects that lead to human disease. They hope to use this approach to treat and eventually cure sickle cell disease, first focusing on curing a mouse model of sickle cell. The new technology would then be applied to human sickle cell patients.

"Nanomedicine is expected to dramatically exceed what has occurred in the field thus far, and our belief is that it will revolutionize medicine," says Bao. "We plan to make this new pediatric nanomedicine center a leader in applying these unique discoveries to treating and curing children's diseases."

The biomedical engineering faculty members who are involved in the CPN activities include: Dr. Wilbur Lam, biomedical engineer; Barbara Boyan, professor and Price Gilbert Jr. Chair in Tissue Engineering and associate dean for research; Niren Murthy, associate professor of biomedical engineering; Michael Davis, assistant professor of biomedical engineering; Phil Santangelo, assistant professor of biomedical engineering; Shuming Nie, professor and the Wallace H. Coulter Distinguished Faculty Chair in Biomedical Engineering; Thomas Barker, assistant professor of biomedical engineering; and Ravi Bellamkonda, professor and associate vice president for research.

####

For more information, please click here

Contacts:
Liz Klipp
Georgia Institute of Technology
404-894-6016

Holly Korschun
Emory University

404-727-3990

Brant Rawls
Childrenís Healthcare of Atlanta
404-785-7577

Copyright © Georgia Tech

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Chemical interactions between silver nanoparticles and thiols: A comparison of mercaptohexanol again September 30th, 2014

A Heartbeat Away? Hybrid "Patch" Could Replace Transplants: TAU researcher harnesses gold nanoparticles to engineer novel biocompatible cardiac patch September 30th, 2014

Iranian Scientists Determine Grain Size, Minimize Time of Nanocomposite Synthesis September 29th, 2014

Nanoparticles Used to Improve Quality of Bone Cement September 29th, 2014

Openings/New facilities/Groundbreaking/Expansion

Brookhaven Lab's National Synchrotron Light Source II Approved to Start Routine Operations: Milestone marks transition to exciting new chapter September 23rd, 2014

FEI Opens New Technology Center in Czech Republic: FEI expands its presence in Brno with the opening of a new, larger facility September 18th, 2014

Nanophase Opens New Polishing Applications Support Laboratory September 9th, 2014

RMIT delivers $30m boost to micro and nano-tech August 26th, 2014

Nanomedicine

A Heartbeat Away? Hybrid "Patch" Could Replace Transplants: TAU researcher harnesses gold nanoparticles to engineer novel biocompatible cardiac patch September 30th, 2014

How things coil: Researchers discover that simulation technology designed for Hollywood can be used as a predictive tool for understanding fundamental engineering problems September 29th, 2014

Nanoparticles Used to Improve Quality of Bone Cement September 29th, 2014

Teijin Aramidís carbon nanotube fibers awarded with Paul Schlack prize: New generation super fibers bring wave of innovations to fiber market September 25th, 2014

Announcements

Chemical interactions between silver nanoparticles and thiols: A comparison of mercaptohexanol again September 30th, 2014

A Heartbeat Away? Hybrid "Patch" Could Replace Transplants: TAU researcher harnesses gold nanoparticles to engineer novel biocompatible cardiac patch September 30th, 2014

Iranian Scientists Determine Grain Size, Minimize Time of Nanocomposite Synthesis September 29th, 2014

Nanoparticles Used to Improve Quality of Bone Cement September 29th, 2014

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE